The long-term effect of a zinc acetate and chlorhexidine diacetate containing mouth rinse on intra-oral halitosis-A randomized clinical trial

2017 ◽  
Vol 44 (10) ◽  
pp. 1010-1019 ◽  
Author(s):  
Seida Erovic Ademovski ◽  
Carina Mårtensson ◽  
Gösta Rutger Persson ◽  
Stefan Renvert
Keyword(s):  
Clinical Trial ◽  
Randomized Clinical Trial ◽  
Zinc Acetate ◽  
Term Effect ◽  
Mouth Rinse ◽  
Long Term Effect

Long-term effect of rehabilitation in coronary artery disease patients: randomized clinical trial of the impact of exercise volume

2010 ◽  
Vol 24 (4) ◽  
pp. 319-327 ◽  
Author(s):  
Dominique Hansen ◽  
Paul Dendale ◽  
Anita Raskin ◽  
Annick Schoonis ◽  
Jan Berger ◽  
...  
Keyword(s):  
Coronary Artery Disease ◽  
Clinical Trial ◽  
Coronary Artery ◽  
Randomized Clinical Trial ◽  
Term Effect ◽  
Long Term Effect ◽  
Artery Disease ◽  
The Impact

scholarly journals Long-term Effect of Losartan on Kidney Disease in American Indians With Type 2 Diabetes: A Follow-up Analysis of a Randomized Clinical Trial

Diabetes Care ◽  
2016 ◽  
Vol 39 (11) ◽  
pp. 2004-2010 ◽  
Author(s):  
Stephanie K. Tanamas ◽  
Pierre-Jean Saulnier ◽  
Gudeta D. Fufaa ◽  
Kevin M. Wheelock ◽  
E. Jennifer Weil ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Clinical Trial ◽  
Kidney Disease ◽  
Randomized Clinical Trial ◽  
American Indians ◽  
Term Effect ◽  
Long Term Effect

scholarly journals Long-term effect of epirubicin on incidence of heart failure in women with breast cancer: insight from a randomized clinical trial

2018 ◽  
Vol 20 (10) ◽  
pp. 1447-1453 ◽  
Author(s):  
Ann Banke ◽  
Emil L. Fosbøl ◽  
Jacob E. Møller ◽  
Gunnar H. Gislason ◽  
Mads Andersen ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Heart Failure ◽  
Clinical Trial ◽  
Randomized Clinical Trial ◽  
Term Effect ◽  
Long Term Effect

scholarly journals Long term effect of depression care management on mortality in older adults: follow-up of cluster randomized clinical trial in primary care

BMJ ◽  
2013 ◽  
Vol 346 (jun05 2) ◽  
pp. f2570-f2570 ◽  
Author(s):  
J. J. Gallo ◽  
K. H. Morales ◽  
H. R. Bogner ◽  
P. J. Raue ◽  
J. Zee ◽  
...  
Keyword(s):  
Primary Care ◽  
Clinical Trial ◽  
Care Management ◽  
Term Effect ◽  
Depression Care ◽  
Long Term Effect ◽  
Depression Care Management ◽  
Cluster Randomized

Transanal versus laparoscopic total mesorectal excision for low rectal cancer: A multicenter randomized phase III clinical trial (TaLaR trial) protocol.

2017 ◽  
Vol 35 (15_suppl) ◽  
pp. TPS3631-TPS3631 ◽  
Author(s):  
Shuangling Luo ◽  
Jianping Wang ◽  
Liang Kang ◽  
Wenhao Chen
Keyword(s):  
Clinical Trial ◽  
Rectal Cancer ◽  
Disease Free Survival ◽  
Term Effect ◽  
Low Rectal Cancer ◽  
Phase Iii ◽  
Transabdominal Approach ◽  
Long Term Effect ◽  
Laparoscopic Tme

TPS3631 Background: Since 1982, Total Mesorectum Excision (TME) was regarded as a golden standard for radical resection of rectal cancer. Current evidences have proved that both open and laparoscopic TME could achieve the comparative oncological safety. However, for low rectal cancer, it remains a challenge to achieve complete TME with safe resections margin by the conventional transabdominal approach, especially in cases such as bulky mesorectum, enlarged prostate, narrow pelvic floor, etc. Transanal TME (TaTME) is a new approach for rectal cancer. Several retrospective studies have showed its advantage of providing better resection quality for low rectal cancer compared with transabdominal approach, but its long-term effect still needs to be explored. Methods: TaLaR trial is an open-label multicenter randomized controlled phase III trial with a non-inferiority design, aiming to compare the short and long term effect between TaTME and laparoscopic TME (lapTME) for low rectal cancer. Patients diagnosed with clinical stage no more than T3N0 or ycT3N2 rectal cancer, inferior border of the tumor from anal verge less than 7cm, are eligible for the present study. A total of 1114 patients (557 per group) will be randomized to either TaTME or lapTME. The primary end-points are 3-year disease-free survival (DFS) and 5-year overall survival (OS). The secondary endpoints include resection quality, postoperative morbidity and mortality, pelvic function and quality of life. Clinical trial information: NCT 02966483.

A long-term effect of subliminally presented words

2010 ◽  
Author(s):  
Andreas T. Breuer ◽  
Michael E. J. Masson ◽  
Glen E. Bodner
Keyword(s):  
Term Effect ◽  
Long Term Effect
Sign in / Sign up

Export Citation Format

Share Document